{"id":"W2162020809","doi":"10.1016/s2352-3026(15)00020-4","title":"90 Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study","year":2015,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Université de Nantes; Université de Bretagne Occidentale","keywords":"Radioimmunotherapy; Medicine; Tolerability; CD22; Refractory (planetary science); Internal medicine; Oncology; Nuclear medicine; Gastroenterology; Lymphoma; CD20; Adverse effect; Immunology; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003710792,0.000277498,0.001002007,0.00007363234,0.0001127466,0.00001692085,0.000259653,0.0001921315,0.00006054754],"category_scores_gemma":[0.0001704346,0.000167053,0.00004637471,0.000549281,0.0002624175,0.00009339877,0.00005486544,0.0006439802,0.0000872092],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002082313,"about_ca_system_score_gemma":0.0003416876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000024401,"about_ca_topic_score_gemma":0.00003224025,"domain_scores_codex":[0.9980975,0.0002217039,0.0004551228,0.0004818467,0.0002780424,0.0004657932],"domain_scores_gemma":[0.9983337,0.0004371008,0.0001955859,0.0006600158,0.0001395016,0.0002341207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3749628,0.08599649,0.1554649,0.00395325,0.003987577,0.04806326,0.05922281,0.00101103,0.2153182,0.004187621,0.03911268,0.008719332],"study_design_scores_gemma":[0.6757367,0.02529367,0.04505213,0.002415959,0.006967308,0.0257617,0.01822426,0.02698887,0.1607122,0.001146228,0.008624675,0.003076343],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916781,0.0002036599,0.0001648147,0.002617671,0.00006888354,0.001722679,0.00002865081,0.0001148681,0.003400693],"genre_scores_gemma":[0.9981154,0.00006074167,0.0002890576,0.0004952631,0.0001722167,0.0003069439,0.00007852217,0.00003429602,0.0004475199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3007739,"threshold_uncertainty_score":0.6812223,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04679705980917849,"score_gpt":0.3532113727698215,"score_spread":0.306414312960643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}